Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
Share:
More In Science
Be Well: Full Body Workout With Lamont J Wallace II
"Vipr" Full Body Workouts
Study: Wegovy Reduces Risks of Heart Attacks, Strokes
A new study shows that the popular diabetes drug Wegovy reduced the risks of serious heart problems by 20% in some people.
New Study Suggests Nostrils Smell Independently
A new study found that our nostrils each have their own sense of smell working independently in some ways.
Promising Results From New Cholesterol Drugs
Two new cholesterol drugs were shown to be safe and effective in new research presented at an annual meeting of the American Heart Association on Sunday.
How Researchers, Farmers and Brewers Want to Safeguard Beer Against Climate Change
Researchers are working with growers to help counter the effects of more volatile weather systems with improved hop varieties that can withstand drought and by adding winter barley to the mix.
One Good Thing: Baby Elephant Interrupts Interview
One Good Thing: Baby Elephant Interrupts Interview
Doctors Perform World's First Human Eye Transplant
Doctors in New York City successfully transplanted a whole human eye for the first time.
U.S. Childhood Vaccination Exemptions Reach Their Highest Level Ever
The proportion of U.S. kindergartners exempted from school vaccination requirements has hit its highest level ever, 3%, U.S. health officials said Thursday.
Doctors Successfully Transplant A Human Eye
Doctors Successfully Transplant A Human Eye
